PD-0002 - KRAS/NRAS and BRAF Mutations in the 20050181 Study of Panitumumab + FOLFIRI for the 2ND-Line Treatment of Metastatic Colorectal Cancer: Updated Analysis

Autor: Peeters, M., Oliner, K., Price, T., Cervantes, A., Sobrero, A., Ducreux, M., Hotko, Y., André, T., Chan, E., Lordick, F., Punt, C., Strickland, A., Wilson, G., Ciuleanu, T., Roman, L., Van Cutsem, E., Yu, H., Jung, A.S., Sidhu, R., Patterson, S.
Zdroj: In Annals of Oncology June 2014 25 Supplement 2:ii5-ii5
Databáze: ScienceDirect